Evidence map›Paper›PMID 34679013›Full record

ArticleToxins2021

Exploration on the Enhancement of Detoxification Ability of Zearalenone and Its Degradation Products of

Jian Ji, Jian Yu, Yang Yang, Xiao Yuan, Jia Yang, Yinzhi Zhang, Jiadi Sun, Xiulan Sun

Open access · goldAbstract read
In one paragraph

Article in Toxins, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 9 papers.

0numbers the graph read from it
0cells of the map it votes in
9citing papers in PubMed
1.8field-weighted citation impact, top 14% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

9 citing papers in PubMed, 14 citations in OpenAlex.

  1. Article
  2. Review
  3. Simultaneous mitigation of ochratoxin A and zearalenone by Amano lipase A: conditions and application.Brazilian journal of microbiology : [publication of the Brazilian Society for Microbiology] · 2025
    Article
  4. Combination ofFrontiers in nutrition · 2025
    Article
  5. Article
  6. Review
  7. Article
  8. Insights into the Metabolic Response ofInternational journal of molecular sciences · 2022
    Article
  9. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 4 institutions in 1 country.

Jian JiState Key Laboratory of Food Science and Technology, School of Food Science and Technology of Jiangnan University, Wuxi 214122, China.ORCID 0000-0001-9405-1084
Jian YuState Key Laboratory of Food Science and Technology, School of Food Science and Technology of Jiangnan University, Wuxi 214122, China.
Yang YangCollege of Food Science and Pharmacy, Xinjiang Agricultural University, Urumqi 830052, China.
Xiao YuanGuangzhou GRG Metrology and Test Co., Ltd., Guangzhou 510630, China.
Jia YangYangzhou Center for Food and Drug Control, Yangzhou 225000, China.
Yinzhi ZhangState Key Laboratory of Food Science and Technology, School of Food Science and Technology of Jiangnan University, Wuxi 214122, China.
Jiadi SunState Key Laboratory of Food Science and Technology, School of Food Science and Technology of Jiangnan University, Wuxi 214122, China.
Xiulan SunState Key Laboratory of Food Science and Technology, School of Food Science and Technology of Jiangnan University, Wuxi 214122, China.
Jiangnan University · CNGuangzhou Metro Group (China) · CNXinjiang Agricultural University · CNZheJiang Institute For Food and Drug Control · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Zearalenone (ZEN) is one of the most common mycotoxin contaminants in food. For food safety, an efficient and environmental-friendly approach to ZEN degradation is significant. In this study, an

Indexed as

Aspergillus nigerInactivation, MetabolicMetabolomeSequence Analysis, DNAZearalenoneZearalenonezearalenone-4-sulfateAspergillus nigerbiodegradation methodsdegradation productsfood safetyzearalenone

Identifiers

PMID34679013
PMCPMC8537726
OpenAlexW3206306205

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.